What are regn share price targets?

Their REGN share price targets range from $720.00 to $1,189.00. On average, they anticipate the company's stock price to reach $989.36 in the next twelve months. This suggests that the stock has a possible downside of 0.5%. View analysts price targets for REGN or view top-rated stocks among Wall Street analysts.

Should you buy regn stock?

The 24 analysts with 12-month price forecasts for REGN stock have an average target of 986.42, with a low estimate of 720 and a high estimate of 1,189. The average target predicts a decrease of -0.31% from the current stock price of 989.48. The average analyst rating for REGN stock from 24 stock analysts is "Buy".

Is Regeneron Pharmaceuticals a good buy?

Regeneron Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is 2.76, and is based on 15 buy ratings, 4 hold ratings, and 1 sell rating. Regeneron Pharmaceuticals has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.